Cargando…

The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy

COPD is a leading cause of mortality and morbidity worldwide and is associated with a high socioeconomic burden. Current treatment includes the use of inhaled corticosteroids and bronchodilators, which can help to improve symptoms and reduce exacerbations; however, there is no solution for restoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riera-Martínez, Lluc, Cànaves-Gómez, Laura, Iglesias, Amanda, Martin-Medina, Aina, Cosío, Borja G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217986/ https://www.ncbi.nlm.nih.gov/pubmed/37240045 http://dx.doi.org/10.3390/ijms24108702

Ejemplares similares

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD
por: Cosío, Borja G., et al.
Publicado: (2015)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2
por: Olguín-Martínez, Enrique, et al.
Publicado: (2022)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex
por: Strickson, Sam, et al.
Publicado: (2023)

ST2 and IL-33 in Pregnancy and Pre-Eclampsia
por: Granne, Ingrid, et al.
Publicado: (2011)

Role of the IL-33-ST2 axis in sepsis
por: Xu, Hui, et al.
Publicado: (2017)

IL-33/ST2 Axis in Organ Fibrosis
por: Kotsiou, Ourania S., et al.
Publicado: (2018)

The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018)

The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022)

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
por: England, Elizabeth, et al.
Publicado: (2023)

Blocking of the IL-33/ST2 Signaling Axis by a Single-Chain Antibody Variable Fragment (scFv) Specific to IL-33 with a Defined Epitope
por: Park, Soo Bin, et al.
Publicado: (2020)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Upregulation of the IL-33/ST2 pathway in dry eye
por: Wang, Shudan, et al.
Publicado: (2019)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer
por: Stojanovic, Bojan, et al.
Publicado: (2023)

Bone marrow characterization in COPD: a multi-level network analysis
por: Toledo-Pons, Nuria, et al.
Publicado: (2018)

Asthma–COPD overlap: identification and optimal treatment
por: Cosío, Borja G., et al.
Publicado: (2018)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
por: Cohen, E. Suzanne, et al.
Publicado: (2015)

Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
por: Abd Rachman Isnadi, Mohammad Faruq, et al.
Publicado: (2018)

IL-33-ST2 Axis in Liver Disease: Progression and Challenge
por: Sun, Zijian, et al.
Publicado: (2017)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
por: Takatori, Hiroaki, et al.
Publicado: (2018)

Emerging Roles of IL-33/ST2 Axis in Renal Diseases
por: Chen, Wei-Yu, et al.
Publicado: (2017)

The Functional Roles of IL-33/ST2 Axis in Ocular Diseases
por: Qian, Yujing, et al.
Publicado: (2020)

The association of serum IL-33/ST2 expression with hepatocellular carcinoma
por: Pan, Xiaolan, et al.
Publicado: (2023)

Asthma-COPD overlap is not a homogeneous disorder: further supporting data
por: Pérez-de-Llano, Luis, et al.
Publicado: (2017)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
por: Saresella, Marina, et al.
Publicado: (2020)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

Circulating IL-32 and IL-33 levels in patients with asthma and COPD: a retrospective cross-sectional study
por: Kim, Min-Hye, et al.
Publicado: (2022)

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD
por: Tworek, Damian, et al.
Publicado: (2018)

Expression and clinical significance of IL-33 and its receptor ST2 in children with obstructive sleep apnea syndrome
por: Zhang, Zibo, et al.
Publicado: (2022)

Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa
por: García-Miguel, Marina, et al.
Publicado: (2013)

The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
por: Mertz, Kirsten D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vqj7eflnmogcur7fq5m44ole8k